Home/Filings/4/0001209191-16-090667
4//SEC Filing

Corbus Pharmaceuticals Holdings, Inc. 4

Accession 0001209191-16-090667

$CRBPCIK 0001595097operating

Filed

Jan 10, 7:00 PM ET

Accepted

Jan 11, 9:12 AM ET

Size

5.6 KB

Accession

0001209191-16-090667

Insider Transaction Report

Form 4
Period: 2016-01-07
Tepper Mark
President and CSO
Transactions
  • Award

    Stock Option(right to buy)

    2016-01-07+240,000240,000 total
    Exercise: $1.40Exp: 2026-01-07Common Stock (240,000 underlying)
Footnotes (1)
  • [F1]The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on January 7, 2017, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on February 7, 2017.

Issuer

Corbus Pharmaceuticals Holdings, Inc.

CIK 0001595097

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001595097

Filing Metadata

Form type
4
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 9:12 AM ET
Size
5.6 KB